Related Experiment Video
Updated: May 14, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Inflammation and immune system interactions in atherosclerosis
Bart Legein1, Lieve Temmerman, Erik A L Biessen
1Experimental Vascular Pathology, Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.
Insights
Atherosclerosis, a key cause of cardiovascular disease (CVD), is now understood as a chronic inflammatory condition. Immune cells significantly influence plaque development and rupture, leading to heart attack and stroke.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Pathology
Background:
- Cardiovascular disease (CVD) is the leading global cause of death.
- Atherosclerosis, the primary driver of CVD, was previously thought to be passive lipid buildup.
- Current understanding identifies atherosclerosis as a chronic inflammatory disease involving immune cells.
Purpose of the Study:
- To review the latest findings on the role of immune cells in atherosclerosis.
- To highlight the complex interplay of innate and adaptive immunity in disease pathogenesis.
Main Methods:
- Literature review of recent research on immune cell involvement in atherosclerosis.
- Synthesis of current knowledge on immune cell subtypes and their functions in plaque development.
Main Results:
- Immune cells are central to atherosclerosis pathogenesis.
- Immune cell activation and interaction dictate plaque stability and rupture risk.
- Specific immune cell subtypes play distinct roles in promoting or resolving inflammation.
Conclusions:
- Atherosclerosis is an immune-mediated inflammatory disease.
- Targeting specific immune pathways offers potential therapeutic strategies for CVD.
- Understanding immune cell dynamics is crucial for predicting and preventing atherosclerotic events like myocardial infarction and stroke.
Abstract:
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for 16.7 million deaths each year. The underlying cause of the majority of CVD is atherosclerosis. In the past, atherosclerosis was considered to be the result of passive lipid accumulation in the vessel wall. Today's picture is far more complex. Atherosclerosis is considered a chronic inflammatory disease that results in the formation of plaques in large and mid-sized arteries. Both cells of the innate and the adaptive immune system play a crucial role in its pathogenesis. By transforming immune cells into pro- and anti-inflammatory chemokine- and cytokine-producing units, and by guiding the interactions between the different immune cells, the immune system decisively influences the propensity of a given plaque to rupture and cause clinical symptoms like myocardial infarction and stroke. In this review, we give an overview on the newest insights in the role of different immune cells and subtypes in atherosclerosis.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Chronic Inflammation: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Coronary Artery Disease II: Pathophysiology

